Aarti Drugs Ltd share price logo

Aarti Drugs Ltd

NSE: AARTIDRUGS

BSE: 524348

Small Cap

Pharma Sector

₹426.35

-2.15

(-0.50%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Aarti Drugs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-39%

Searches for Aarti Drugs on INDmoney have decreased by 39% over the last 30 days.

Average holding period of indmoney investors

46 days

INDmoney investors hold Aarti Drugs shares for an average of 46 days.

Key Events for Aarti Drugs

Last Dividend Declared

₹2.00 per share, declared on 03/02/2026

View Dividend History

Aarti Drugs Stock Performance

as on September 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹424.00
    ₹439.90
    downward going graph

    0.55%

    Downside

    3.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹318.95
    ₹534.55
    downward going graph

    25.19%

    Downside

    25.38%

    Upside

    downward going graph

Aarti Drugs share price movements today

Previous Close
₹428.50
Open
₹428.00
Volume
1.44L
Upper Circuit
₹514.20
Lower Circuit
₹342.80
Day's Low - High
₹424.00 - ₹439.90
52 Week Low - High
₹318.95 - ₹534.55

Aarti Drugs Historical Returns

1 Month Return
+ 4.32 %
3 Month Return
+ 14.14 %
1 Year Return
-15.75 %
3 Year Return
-26.68 %
5 Year Return
-30.93 %

Aarti Drugs Fundamentals

as on September 15, 2026 at 4:01 pm IST

Market Cap

₹3,910.92 Cr

Return on Equity (ROE)

12.74

PE Ratio (TTM)

20.47

Return on capital employed (ROCE)

11.64

Industry PE ratio

51.81

Beta (LTM)

0.84

P/B Ratio

2.08

Dividend Yield

0.63

PEG Ratio

81.89

Quarterly Earnings Growth YOY

-7.12

EPS (TTM)

21.36

Book Value

169.7

Aarti Drugs Stock Valuation

as on September 15, 2026 at 4:01 pm IST

Aarti Drugs in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (20.47x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (57.24x)

August 24, 2020

LowHigh

Today’s Price to Earnings Ratio: 20.47x

Aarti Drugs Technical Analysis

Track how Aarti Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish8
Bullish4
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.13
Bearish
CCI (20)
664.1
Bearish
RSI (14)
52.16
Neutral
Momentum (10)
-0.1
Neutral
ADI (14)
17.17
Neutral
Ultimate Oscillator (7,14,28)
23.65
Bearish

Moving Averages

Name

Value

Action

SMA (20)
426.84
Bearish
EMA (20)
426.71
Bullish
VWMA (20)
426.82
Bearish
SMA (50)
426.4
Bullish
EMA (50)
426.75
Bullish
SMA (200)
430.35
Bearish
EMA (200)
429.31
Bearish
KAMA (200)
426.56
Bullish
DEMA (200)
426.92
Bearish

Aarti Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarti Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aarti Drugs Ltd image
Aarti Drugs Ltd
HOLD3,910.92-6.19%0.641942,565
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,841.93-3.68%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,331.4412.71%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,360.95-6.77%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,675.3644.19%0.682811,703
See all

Market expectation of Aarti Drugs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Aarti Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
641.54
605.94
619.99
555.34
598.33
556.6
676.76
590.51
652.79
601.71
720.3
702.78
Other Income
0.69
1.67
1.08
1.11
1.48
11.9
1.87
0.31
0.09
1.23
0.76
0.81
Total Income
642.23
607.61
621.07
556.45
599.81
568.5
678.63
590.82
652.88
602.94
721.06
703.59
Expenses
565.1
535.8
534.18
490.38
531.28
494.87
583.43
516.43
568.51
546.68
624.5
606.67
Operating Profit
76.44
70.14
85.81
64.96
67.05
61.73
93.33
74.08
84.28
55.03
95.8
96.11
Operating Profit Margin %
11.92%
11.58%
13.84%
11.7%
11.21%
11.09%
13.79%
12.55%
12.91%
9.15%
13.3%
13.68%
Profit Before Interest, Tax and Depreciation
77.13
71.81
86.89
66.07
68.53
73.63
95.2
74.39
84.37
56.26
96.56
96.92
Interest
8.25
7.6
9.13
8.71
8.93
9.07
9.16
8.56
7.7
9.29
8.16
9.22
Depreciation
12.61
12.66
13.58
13.38
13.72
13.8
14.88
14.72
16.26
17.95
18.04
18.46
Profit Before Tax
56.27
51.55
64.18
43.98
45.88
50.76
71.16
51.11
60.41
29.02
70.36
69.24
Tax Paid
16.67
14.84
16.87
10.71
10.92
13.67
8.39
-2.86
15.25
-11.53
15.1
19.11
Profit After Tax
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
45.16
40.55
55.26
50.13
Total Net profit including share of profit / Loss from associate company
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
45.16
40.55
55.26
50.13
EPS
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
6.05
5.49
Actual EPS
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
6.05
5.49
Adjusted EPS
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
6.05
5.49
Diluted EPS
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
6.05
5.49

Aarti Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,243.63
1,560.94
1,806.09
2,154.78
2,488.65
2,716.05
2,528.58
2,387.03
2,565.31
Other Income
1.05
6.18
5.95
4.74
11.32
2.19
4.03
16.36
2.39
Total Income
1,244.68
1,567.12
1,812.04
2,159.52
2,499.97
2,718.24
2,532.61
2,403.39
2,567.7
Expenses
1,045.15
1,353.58
1,544.27
1,717.67
2,159.21
2,410.45
2,212.12
2,099.97
2,256.12
Operating Profit
198.48
207.36
261.82
437.11
329.44
305.6
316.46
287.06
309.19
Operating Profit Margin %
15.96%
13.28%
14.5%
20.29%
13.24%
11.25%
12.52%
12.03%
12.05%
Profit Before Interest, Tax and Depreciation
199.53
213.54
267.77
441.85
340.76
307.79
320.49
303.42
311.58
Interest
34.96
39.96
33.73
22.96
20.75
33.29
33.52
35.87
33.71
Depreciation
40.06
42.56
48.75
49.88
50.05
50.32
51.45
55.78
66.97
Profit Before Tax
124.51
131.02
185.29
369.01
269.96
224.18
235.52
211.77
210.9
Tax Paid
42.2
41.27
43.89
88.61
64.96
57.82
63.93
43.67
15.96
Profit After Tax
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
194.94
Total Net profit including share of profit / Loss from associate company
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
194.94
EPS
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
21.36
Actual EPS
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
21.36
Adjusted EPS
8.6
9.62
15.14
30.09
22.12
17.97
18.56
18.35
21.36
Diluted EPS
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
21.36

Aarti Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
133.3
174.75
69.77
143.09
250.74
154.95
70.41
133.32
358.92
244.58
253.54
Cash Flow from Investing Activities
-98.79
-106.97
-73.54
-61.67
-33.21
-71.77
-149.63
-163.97
-223.64
-164.63
-173.4
Cash Flow from Financing Activities
-33.26
-68.22
3.92
-80.06
-215.42
-81.14
92.02
16.55
-136.03
-82.12
-77.45
Net Cash Flow
1.24
-0.45
0.15
1.35
2.13
2.04
12.8
-14.11
-0.76
-2.17
2.69

Aarti Drugs Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
57.47%
57.13%
55.67%
55.64%
55.38%
55.48%
55.22%
54.72%
55.03%
55.03%
54.43%
DII
5.26%
5.99%
7.35%
7.84%
8.77%
9.7%
9.94%
9.9%
10.12%
10.22%
10.29%
FII
2.1%
2.56%
2.96%
2.5%
2.28%
2.25%
2.26%
2.69%
2.15%
1.58%
1.52%
Public
35.17%
34.31%
34.02%
34.02%
33.57%
32.57%
32.58%
32.69%
32.7%
33.18%
33.75%
Total Outstanding Shares
9,19,35,000
9,19,35,000
9,19,35,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
Total Shareholders
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761
1,60,260
1,52,252
1,48,363
1,44,946
1,43,476

Mutual Funds Buying / Exiting Aarti Drugs

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Aarti Drugs

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Groww Nifty Total Market Index Fund Direct Growth

Groww Nifty Total Market Index Fund Direct Growth

₹0.03 Cr

₹0.00 Cr (+0.38%)

0.01%

Mutual Funds Exiting Aarti Drugs

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

ICICI Prudential Healthcare Fund Direct Growth

ICICI Prudential Healthcare Fund Direct Growth

₹79.52 Cr

₹0.01 Cr (-0.02%)

1.1%

Aarti Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Aarti Drugs.

  • Aarti Drugs Ltd Earnings Results

    Aarti Drugs Ltd’s net profit fell -6.94% since last year same period to ₹50.17Cr in the Q1 2026-2027. On a quarterly growth basis, Aarti Drugs Ltd has generated -9.1% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarti Drugs Ltd Dividends February,2026

    In the quarter ending December 2025, Aarti Drugs Ltd has declared dividend of ₹2.00 per share on 03 Feb 2026 - translating a dividend yield of 0.47%.

    Read More about Dividends

Indices Featuring Aarti Drugs Stock

Check stock indices that include Aarti Drugs.

BSE Healthcare

₹50,478.81

-759.32 (▲1.48%)

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AARTIDRUGS stock has moved up by 1.7%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.18% to 33.75% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 165.3% return, outperforming this stock by 191.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 53.9% return, outperforming this stock by 69.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 55.19 Cr → 50.17 Cr (in ₹), with an average decrease of 9.1% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.58% to 1.52% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 55.03% to 54.43% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 10.14% to 10.08% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 721.06 Cr → 703.59 Cr (in ₹), with an average decrease of 2.4% per quarter

About Aarti Drugs Ltd

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Revenue: ₹702.78Cr as on June 2026 (Q1 FY27)
Net Profit: ₹50.13Cr as on June 2026 (Q1 FY27)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash M Patil
E-voting on sharesClick here to vote

FAQs

What is Aarti Drugs share price today?

Aarti Drugs share price today stands at ₹426.35 as on at the close of the market. Aarti Drugs share today touched a day high of ₹439.9 and a low of ₹424.

What is the 52 week high and 52 week low range for Aarti Drugs share?

Aarti Drugs touched a 52 week high of ₹534.55 and a 52 week low of ₹318.95. Aarti Drugs share price today i.e. is closed at ₹426.35, which is -20.24% down from its 52 week high and 33.67% up from its 52 week low.

What is Aarti Drugs's market capitalisation today?

Aarti Drugs market capitalisation is ₹3,910.92 Cr as on .

How to buy Aarti Drugs shares?

To buy Aarti Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AARTIDRUGS or Aarti Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarti Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarti Drugs trading volume today?

Aarti Drugs trading volume is 1.44L as on . This means that 1.44L shares of Aarti Drugs were bought and sold on the stock market during today's trading session.